Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.51 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.46 |
| ▸ | RECQL | P46063 | 1/20 | 0.46 |
| ▸ | HBB | P68871 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | TP53 | P04637 | 2/20 | 0.44 |
| ▸ | STAT5B | P51692 | 1/20 | 0.44 |
| ▸ | HMOX1 | P09601 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | ALPG | P10696 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22118502 | 0.84 | HSD17B10 (0.51) | ALDH1A1HSD17B10ALOX15L3MBTL1MEN1 | |
| SCHEMBL10633527 | 0.83 | HSD17B10 (0.61) | ALDH1A1HSD17B10ALOX15L3MBTL1MEN1 | |
| SCHEMBL5206717 | 0.81 | TP53 (0.56) | ALDH1A1HSD17B10ALOX15MEN1KMT2A | |
| SCHEMBL28046898 | 0.80 | HSD17B10 (0.48) | ALDH1A1HSD17B10ALOX15L3MBTL1MEN1 | |
| SCHEMBL16035137 | 0.79 | HSD17B10 (0.47) | ALDH1A1HSD17B10ALOX15L3MBTL1MEN1 | |
| SCHEMBL6629991 | 0.79 | ALDH1A1 (0.44) | ALDH1A1HSD17B10ALOX15L3MBTL1MEN1 | |
| SCHEMBL11676991 | 0.79 | TP53 (0.41) | ALDH1A1HSD17B10ALOX15L3MBTL1MEN1 | |
| SCHEMBL10633627 | 0.79 | TP53 (0.50) | ALDH1A1MEN1KMT2APOLBMAPT | |
| SCHEMBL22035923 | 0.78 | ALDH1A1 (0.46) | ALDH1A1HSD17B10ALOX15L3MBTL1MEN1 | |
| SCHEMBL48809 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1556500-A1 | SIMPLE ENZYMATIC PROCESS FOR PREPARING CEFAZOLIN | Bioferma Murcia, S.A. (ES) | 2005-07-27 | — | — | EP | claimed |
| WO-2004039997-A1 | SIMPLE ENZYMATIC PROCESS FOR PREPARING CEFAZOLIN | BIOFERMA MURCIA, S.A. (ES) | 2004-05-13 | — | — | WO | claimed |
| EP-1416054-A1 | Simple enzymatic process for preparing cefazolin | Bioferma Murcia, S.A. (ES) | 2004-05-06 | — | — | EP | claimed |
| CN-115397979-A | Penicillin G acylase mutants with increased cefazolin productivity and uses thereof | 艾美科健株式会社 | 2022-11-25 | — | — | CN | disclosed |
| WO-2021096298-A1 | PENICILLIN G ACYLASE MUTANT HAVING INCREASED CEFAZOLINE PRODUCTIVITY AND USE THEREOF | 아미코젠주식회사 | 2021-05-20 | — | — | WO | disclosed |
| US-8093400-B2 | Compounds useful in therapy | PFIZER INC. (US) | 2012-01-10 | — | — | US | disclosed |
| US-8093400-B2 | Compounds useful in therapy | PFIZER INC. (US) | 2012-01-10 | — | — | US | disclosed |
| US-8093400-B2 | Compounds useful in therapy | PFIZER INC. (US) | 2012-01-10 | — | — | US | disclosed |
| US-20100317652-A1 | Compounds Useful In Therapy | PFIZER INC | 2010-12-16 | — | — | US | disclosed |
| US-20100317652-A1 | Compounds Useful In Therapy | PFIZER INC | 2010-12-16 | — | — | US | disclosed |
| US-20100317652-A1 | Compounds Useful In Therapy | PFIZER INC | 2010-12-16 | — | — | US | disclosed |
| WO-2004039997-A1 | SIMPLE ENZYMATIC PROCESS FOR PREPARING CEFAZOLIN | BIOFERMA MURCIA, S.A. (ES) | 2004-05-13 | — | — | WO | disclosed |
| EP-1416054-A1 | Simple enzymatic process for preparing cefazolin | Bioferma Murcia, S.A. (ES) | 2004-05-06 | — | — | EP | disclosed |
| US-4616024-A | Dihydropyridine anti-ischaemic and antihypertensive agents | PFIZER INC. (US) | 1986-10-07 | — | — | US | disclosed |
| EP-0100189-B1 | DIHYDROPYRIDINE ANTI-ISCHAEMIC AND ANTIHYPERTENSIVE AGENTS | Pfizer Limited (GB) | 1986-05-28 | — | — | EP | disclosed |
| US-4515799-A | Dihydropyridine anti-ischaemic and antihypertensive agents | PFIZER INC. (US) | 1985-05-07 | — | — | US | disclosed |
| EP-0100189-A2 | Dihydropyridine anti-ischaemic and antihypertensive agents | Pfizer Limited (GB) | 1984-02-08 | — | — | EP | disclosed |
| US-4314059-A | Process for preparing cephalosporin compounds | SHIBUYA CHISEI | 1982-02-02 | — | — | US | disclosed |
| US-4258195-A | Novel thiol esters and process for preparing cephalosporin compounds using same | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1981-03-24 | — | — | US | disclosed |
| EP-0004570-A1 | Thiol esters, process for their preparation, pharmaceutical compositions containing them and a process for preparing cephalosporin compounds using the same | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1979-10-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100317652-A1 | Compounds Useful In Therapy | AVPR1A, AVPR1B, AVPR2 | ALDH1A1 2031/4885HSD17B10 2776/4885ALOX15 750/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.